Close

Vanda Pharmaceuticals (VNDA), Taro Pharma Enter Settlement over Generic Fanapt ANDA

October 24, 2016 4:06 PM EDT Send to a Friend
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced it has entered into a License Agreement (the License Agreement) with Taro Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login